ArticleBlood cancer journal2022

γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation.

Hailin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.